Shagun Singh
Stock Analyst at RBC Capital
(2.36)
# 1,396
Out of 4,413 analysts
125
Total ratings
41.96%
Success rate
-2.03%
Average return
Main Sectors:
17 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BSX Boston Scientific | Maintains: Outperform | $78 → $82 | $72.21 | +13.56% | 10 | Apr 25, 2024 | |
| INSP Inspire Medical Systems | Initiates: Outperform | $285 | $244.00 | +16.80% | 1 | Apr 19, 2024 | |
| ABT Abbott Laboratories | Maintains: Outperform | $128 → $125 | $106.29 | +17.60% | 8 | Apr 18, 2024 | |
| JNJ Johnson & Johnson | Maintains: Outperform | $181 → $175 | $151.18 | +15.76% | 6 | Apr 17, 2024 | |
| SYK Stryker | Maintains: Outperform | $360 → $386 | $328.12 | +17.64% | 13 | Apr 15, 2024 | |
| NVRO Nevro | Maintains: Sector Perform | $18 → $16 | $10.41 | +53.70% | 7 | Apr 15, 2024 | |
| EW Edwards Lifesciences | Maintains: Outperform | $95 → $101 | $84.30 | +19.81% | 13 | Apr 15, 2024 | |
| DXCM DexCom | Initiates: Outperform | $165 | $125.88 | +31.08% | 1 | Mar 12, 2024 | |
| ZYXI Zynex | Maintains: Outperform | $13 → $15 | $11.77 | +27.44% | 2 | Mar 1, 2024 | |
| AXNX Axonics | Reiterates: Sector Perform | $71 | $66.87 | +6.18% | 5 | Feb 29, 2024 | |
| TFX Teleflex | Maintains: Outperform | $272 → $265 | $211.54 | +25.27% | 15 | Feb 23, 2024 | |
| PEN Penumbra | Reiterates: Outperform | $289 | $205.29 | +40.78% | 7 | Feb 23, 2024 | |
| MDT Medtronic | Reiterates: Sector Perform | $92 | $80.89 | +13.73% | 11 | Feb 21, 2024 | |
| ZBH Zimmer Biomet Holdings | Reiterates: Outperform | $140 | $119.56 | +17.10% | 8 | Feb 9, 2024 | |
| ISRG Intuitive Surgical | Maintains: Outperform | $400 → $432 | $371.70 | +16.22% | 10 | Jan 24, 2024 | |
| OM Outset Medical | Downgrades: Sector Perform | $14 → $6 | $2.85 | +110.53% | 6 | Jan 12, 2024 | |
| GMED Globus Medical | Reiterates: Outperform | $70 | $50.43 | +38.81% | 2 | Jan 11, 2024 |
Boston Scientific
Apr 25, 2024
Maintains: Outperform
Price Target: $78 → $82
Current: $72.21
Upside: +13.56%
Inspire Medical Systems
Apr 19, 2024
Initiates: Outperform
Price Target: $285
Current: $244.00
Upside: +16.80%
Abbott Laboratories
Apr 18, 2024
Maintains: Outperform
Price Target: $128 → $125
Current: $106.29
Upside: +17.60%
Johnson & Johnson
Apr 17, 2024
Maintains: Outperform
Price Target: $181 → $175
Current: $151.18
Upside: +15.76%
Stryker
Apr 15, 2024
Maintains: Outperform
Price Target: $360 → $386
Current: $328.12
Upside: +17.64%
Nevro
Apr 15, 2024
Maintains: Sector Perform
Price Target: $18 → $16
Current: $10.41
Upside: +53.70%
Edwards Lifesciences
Apr 15, 2024
Maintains: Outperform
Price Target: $95 → $101
Current: $84.30
Upside: +19.81%
DexCom
Mar 12, 2024
Initiates: Outperform
Price Target: $165
Current: $125.88
Upside: +31.08%
Zynex
Mar 1, 2024
Maintains: Outperform
Price Target: $13 → $15
Current: $11.77
Upside: +27.44%
Axonics
Feb 29, 2024
Reiterates: Sector Perform
Price Target: $71
Current: $66.87
Upside: +6.18%
Teleflex
Feb 23, 2024
Maintains: Outperform
Price Target: $272 → $265
Current: $211.54
Upside: +25.27%
Penumbra
Feb 23, 2024
Reiterates: Outperform
Price Target: $289
Current: $205.29
Upside: +40.78%
Medtronic
Feb 21, 2024
Reiterates: Sector Perform
Price Target: $92
Current: $80.89
Upside: +13.73%
Zimmer Biomet Holdings
Feb 9, 2024
Reiterates: Outperform
Price Target: $140
Current: $119.56
Upside: +17.10%
Intuitive Surgical
Jan 24, 2024
Maintains: Outperform
Price Target: $400 → $432
Current: $371.70
Upside: +16.22%
Outset Medical
Jan 12, 2024
Downgrades: Sector Perform
Price Target: $14 → $6
Current: $2.85
Upside: +110.53%
Globus Medical
Jan 11, 2024
Reiterates: Outperform
Price Target: $70
Current: $50.43
Upside: +38.81%